No results for ‘’
Alpa Laboratories Ltd
₹68.65
(1.02%)
Wed, 17 Jun 2026, 06:17 am
Health Technology
Pharmaceuticals: Major
24.5KAlpa Laboratories Enterprise Value (EV)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 8.60 | 42.94 | 37.11 | 26.28 | 34.80 | 0 | 0 | 0 | 11.75 | 33.67 | 29.25 | 55.12 | 16.01 | 10.50 | 10.38 | 8.99 | 10.46 | 11.23 |
| Price to book ratio | 0 | 0 | 0.64 | 0.17 | 0.31 | 0.24 | 0.19 | 0.18 | 0.23 | 0.27 | 0.86 | 0.90 | 0.84 | 0.57 | 0.30 | 0.71 | 1.20 | 0.84 | 1.16 | 1.28 |
| Price to sales ratio | 0 | 0 | 0.46 | 0.14 | 0.32 | 0.29 | 0.34 | 0.31 | 0.38 | 0.41 | 1.52 | 1.36 | 1.34 | 0.74 | 0.35 | 0.79 | 1.32 | 1.23 | 1.63 | 2 |
| Price to cash flow ratio | 0 | 0 | 11.51 | 7.15 | 57.51 | 5.17 | 6.13 | 21.08 | 3.46 | 0 | 0 | 4.33 | 15.21 | 24.41 | 1.54 | 0 | 42.02 | 11.42 | 29.99 | 10.69 |
| Enterprise value | 0 | 0 | 77.64Cr | 30.08Cr | 36.69Cr | 32.14Cr | 30Cr | 32.94Cr | 33.13Cr | -20.34Cr | 67.97Cr | 51.11Cr | 48.78Cr | 26.56Cr | -15.39Cr | 25.05Cr | 78.53Cr | 34.62Cr | 87.89Cr | 106Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 17.69 | 0 | 25.22 | 25.74 | 19.07 | 14.52 | 9.03 | -9.21 | 11.61 | 7.72 | 14.28 | 178.76 | -3.05 | 3.08 | 8.16 | 4.29 | 10.24 | 24.20 |
| Debt to equity ratio | 0.68 | 0.68 | 0.20 | 0.16 | 0.08 | 0.10 | 0.12 | 0.18 | 0.26 | 0.33 | 0.26 | 0.11 | 0.06 | 0.02 | 0 | 0 | 0.03 | 0.02 | 0.03 | 0 |
| Return on equity % | 32.80 | 28.75 | 11.34 | 0.40 | 0.83 | 0.93 | 0.54 | -4.57 | -5.67 | -1.60 | 7.61 | 2.68 | 2.91 | 1.03 | 1.87 | 6.97 | 12.29 | 9.82 | 11.71 | 12.06 |
Alpa Laboratories Ltd Enterprise Value
The Alpa Laboratories Ltd Enterprise Value is a key financial metric used by investors to evaluate Alpa Laboratories Ltd's valuation, profitability, and overall financial performance. Tracking the Alpa Laboratories Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Alpa Laboratories Ltd (NSE: ALPA, BSE: 532878) is currently trading at ₹68.65, with a market capitalization of ₹144.46Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Alpa Laboratories Ltd Enterprise Value is essential for fundamental analysis.
Alpa Laboratories Ltd Enterprise Value Current Value
The current Alpa Laboratories Ltd Enterprise Value stands at 106Cr.
The latest Alpa Laboratories Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Alpa Laboratories Ltd Enterprise Value Historical Trend
The Alpa Laboratories Ltd Enterprise Value has shown the following historical trend:
- 2024: 106Cr
- 2023: 87.89Cr
- 2022: 34.62Cr
- 2021: 78.53Cr
- 2020: 25.05Cr
The recent rise in Alpa Laboratories Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Alpa Laboratories Ltd Enterprise Value Indicates for Investors
The Alpa Laboratories Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Alpa Laboratories Ltd.
Alpa Laboratories Ltd Enterprise Value Analysis Summary
The Alpa Laboratories Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Alpa Laboratories Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Alpa Laboratories Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.